JPRN-UMIN000016465
Completed
未知
Prospective clinical research on safety and efficacy of TAPCOM Combination Ophthalmic Solution switched from Xalatan Ophthalmic Solution - Prospective clinical research on safety and efficacy of TAPCOM Combination Ophthalmic Solution switched from Xalatan Ophthalmic Solution
Overview
- Phase
- 未知
- Intervention
- Not specified
- Conditions
- primary open angle glaucoma or ocular hypertension
- Sponsor
- Hiroshima University Hospital
- Enrollment
- 85
- Status
- Completed
- Last Updated
- 2 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- Not provided
Exclusion Criteria
- •Patients with allergy to the ingredients used in the present study Patients who are contraindicated to Beta blockers Patients who the investigator consider ineligible for enrollment
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Phase 2
Prospective study of efficacy, safety and pharmacokinetics of transcatheter arterial chemoembolization (TACE) with miriplatin for hepatocellular carcinoma.Hepatocellular carcinoma (HCC)JPRN-UMIN000006926Kawasaki Medical School20
Completed
Not Applicable
Clinical research to evaluation the safety and efficacy of volume-reduced washed platelets in children with cancer.children with cancer.JPRN-UMIN000031481Shinshu University50
Completed
Not Applicable
A clinical study investigating the safety and efficacy of daikenchuto for the treatment of abdominal bloating.JPRN-UMIN000016442Izumo-City General Medical Center80
Completed
Not Applicable
Clinical study to investigate safety and efficacy on a combined use of rituximab and auto-gamma/delta T cell therapy for CD20-positive B-cell lymphoma.CD20-positive B-cell lymphomaJPRN-UMIN000003641Japanese Red Cross Medical Center15
Completed
Phase 1
Clinical study to investigate safety and efficacy on autologous tumor lysate-pulsed dendritic cellsMalignant GliomaJPRN-UMIN000001903Osaka National Hospital, National Hospital Organization15